• Explore /
  • Poster
  • / Effect of neoadjuvant pertuzumab-containing regimens on pathologic complete response rates in stage II-III HER2-neu positive breast cancer: A retrospective, single institutional experience.

Effect of neoadjuvant pertuzumab-containing regimens on pathologic complete response rates in stage II-III HER2-neu positive breast cancer: A retrospective, single institutional experience.

Abstract Poster

Authors

Rashmi Murthy

Rashmi Krishna Murthy

The University of Texas MD Anderson Cancer Center, Houston, TX

Rashmi Krishna Murthy , Takeo Fujii , Kenneth R. Hess , Akshara Singareeka Raghavendra , Bora Lim , Carlos Hernando Barcenas , Hong Amy Zhang , Mariana Chavez-Mac Gregor , Elizabeth Ann Mittendorf , Jennifer Keating Litton , Sharon Hermes Giordano , Alastair Mark Thompson , Vicente Valero , Debu Tripathy , Naoto T. Ueno

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Citation

J Clin Oncol 35, 2017 (suppl; abstr 580)

DOI

10.1200/JCO.2017.35.15_suppl.580

Abstract #

580

Poster Bd #

180

Abstract Disclosures

Similar Posters

First Author: Hong-Fei Gao

First Author: Giacomo Pelizzari

First Author: Laura Spring

First Author: Jeremy Meyer Force